| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 65 | 2025 | 916 | 8.840 |
Why?
|
| Heart Failure | 53 | 2025 | 1491 | 5.890 |
Why?
|
| Heart Transplantation | 12 | 2025 | 873 | 3.370 |
Why?
|
| Cardiac Surgical Procedures | 11 | 2021 | 508 | 2.410 |
Why?
|
| Heart Valve Prosthesis Implantation | 10 | 2023 | 192 | 2.160 |
Why?
|
| Ventricular Function, Left | 21 | 2021 | 540 | 2.140 |
Why?
|
| Diverticulum | 4 | 2021 | 45 | 1.910 |
Why?
|
| Intra-Aortic Balloon Pumping | 7 | 2024 | 100 | 1.860 |
Why?
|
| Hemodynamics | 17 | 2020 | 747 | 1.800 |
Why?
|
| Tissue Engineering | 7 | 2016 | 204 | 1.770 |
Why?
|
| Aorta, Thoracic | 8 | 2022 | 154 | 1.680 |
Why?
|
| Aortic Valve Insufficiency | 9 | 2021 | 133 | 1.570 |
Why?
|
| Prosthesis Implantation | 9 | 2020 | 134 | 1.510 |
Why?
|
| Heart Ventricles | 16 | 2020 | 664 | 1.510 |
Why?
|
| Tricuspid Valve Insufficiency | 6 | 2025 | 108 | 1.480 |
Why?
|
| Retrospective Studies | 50 | 2025 | 10973 | 1.420 |
Why?
|
| Aortic Aneurysm, Thoracic | 5 | 2025 | 101 | 1.390 |
Why?
|
| Subclavian Artery | 4 | 2021 | 43 | 1.380 |
Why?
|
| Heart Valve Diseases | 4 | 2018 | 103 | 1.130 |
Why?
|
| Cannula | 7 | 2020 | 59 | 1.120 |
Why?
|
| Extracellular Matrix | 4 | 2016 | 258 | 1.120 |
Why?
|
| Aortic Valve | 12 | 2021 | 258 | 1.110 |
Why?
|
| Middle Aged | 84 | 2025 | 29428 | 1.110 |
Why?
|
| Cardioplegic Solutions | 2 | 2020 | 17 | 1.100 |
Why?
|
| Coronary Sinus | 2 | 2020 | 11 | 1.100 |
Why?
|
| Pericardium | 7 | 2018 | 73 | 1.090 |
Why?
|
| Humans | 121 | 2025 | 98088 | 1.060 |
Why?
|
| Treatment Outcome | 40 | 2025 | 9711 | 1.040 |
Why?
|
| Myocardium | 5 | 2021 | 578 | 1.000 |
Why?
|
| Postoperative Complications | 16 | 2025 | 2681 | 0.980 |
Why?
|
| Mitral Valve | 7 | 2021 | 229 | 0.950 |
Why?
|
| Deglutition Disorders | 2 | 2020 | 126 | 0.940 |
Why?
|
| Heart Atria | 5 | 2020 | 255 | 0.930 |
Why?
|
| Sternotomy | 3 | 2022 | 25 | 0.930 |
Why?
|
| Blood Vessel Prosthesis Implantation | 4 | 2025 | 246 | 0.930 |
Why?
|
| Ventricular Dysfunction, Right | 4 | 2025 | 161 | 0.920 |
Why?
|
| Hospital Mortality | 6 | 2022 | 541 | 0.920 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2022 | 238 | 0.910 |
Why?
|
| Male | 85 | 2025 | 47077 | 0.900 |
Why?
|
| Device Removal | 4 | 2020 | 170 | 0.900 |
Why?
|
| Female | 86 | 2025 | 51541 | 0.880 |
Why?
|
| Tricuspid Valve | 6 | 2025 | 95 | 0.860 |
Why?
|
| Aged | 57 | 2025 | 21758 | 0.840 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2020 | 244 | 0.840 |
Why?
|
| Ventricular Function, Right | 5 | 2020 | 146 | 0.800 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2023 | 15 | 0.800 |
Why?
|
| Aortic Rupture | 2 | 2022 | 53 | 0.790 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 33 | 0.770 |
Why?
|
| Regeneration | 3 | 2016 | 162 | 0.760 |
Why?
|
| Defibrillators, Implantable | 4 | 2025 | 190 | 0.750 |
Why?
|
| Pacemaker, Artificial | 4 | 2025 | 119 | 0.750 |
Why?
|
| Robotics | 4 | 2011 | 271 | 0.750 |
Why?
|
| Catheter Ablation | 5 | 2008 | 381 | 0.700 |
Why?
|
| Mitral Valve Insufficiency | 4 | 2016 | 179 | 0.680 |
Why?
|
| Recovery of Function | 5 | 2021 | 370 | 0.680 |
Why?
|
| Ventricular Remodeling | 2 | 2015 | 108 | 0.670 |
Why?
|
| Thrombosis | 5 | 2020 | 318 | 0.660 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2022 | 103 | 0.660 |
Why?
|
| Swine | 12 | 2017 | 592 | 0.660 |
Why?
|
| Echocardiography, Doppler | 8 | 2020 | 137 | 0.640 |
Why?
|
| Heart Arrest, Induced | 2 | 2020 | 30 | 0.620 |
Why?
|
| Pulmonary Wedge Pressure | 6 | 2020 | 123 | 0.610 |
Why?
|
| Heart | 5 | 2019 | 527 | 0.600 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 82 | 0.600 |
Why?
|
| Vena Cava, Superior | 2 | 2020 | 54 | 0.600 |
Why?
|
| Heart Rate | 2 | 2022 | 534 | 0.590 |
Why?
|
| Echocardiography, Three-Dimensional | 6 | 2018 | 339 | 0.590 |
Why?
|
| Endocarditis, Bacterial | 2 | 2011 | 38 | 0.580 |
Why?
|
| Carbon Dioxide | 1 | 2019 | 202 | 0.550 |
Why?
|
| Cardiac Catheterization | 6 | 2020 | 307 | 0.540 |
Why?
|
| Time Factors | 17 | 2020 | 5567 | 0.540 |
Why?
|
| Thromboembolism | 4 | 2019 | 124 | 0.540 |
Why?
|
| Robotic Surgical Procedures | 2 | 2021 | 411 | 0.530 |
Why?
|
| Minimally Invasive Surgical Procedures | 5 | 2021 | 309 | 0.520 |
Why?
|
| Follow-Up Studies | 18 | 2025 | 4025 | 0.520 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2015 | 264 | 0.500 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2008 | 86 | 0.500 |
Why?
|
| Coronary Artery Bypass | 3 | 2020 | 231 | 0.500 |
Why?
|
| Survival Rate | 8 | 2022 | 2041 | 0.490 |
Why?
|
| Clinical Competence | 1 | 2022 | 865 | 0.480 |
Why?
|
| Adult | 31 | 2025 | 29539 | 0.470 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2015 | 57 | 0.450 |
Why?
|
| Cohort Studies | 9 | 2022 | 3212 | 0.440 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2015 | 8 | 0.440 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2017 | 642 | 0.440 |
Why?
|
| Prosthesis Design | 11 | 2020 | 308 | 0.440 |
Why?
|
| Vascular Malformations | 1 | 2015 | 19 | 0.440 |
Why?
|
| Drug Carriers | 1 | 2015 | 90 | 0.430 |
Why?
|
| Counterpulsation | 3 | 2020 | 21 | 0.430 |
Why?
|
| Aneurysm | 1 | 2015 | 59 | 0.420 |
Why?
|
| Echocardiography | 12 | 2020 | 783 | 0.420 |
Why?
|
| Cysts | 1 | 2015 | 100 | 0.410 |
Why?
|
| Electrocardiography | 6 | 2021 | 527 | 0.400 |
Why?
|
| Intestine, Small | 1 | 2015 | 318 | 0.390 |
Why?
|
| Prospective Studies | 21 | 2025 | 4823 | 0.390 |
Why?
|
| Risk Assessment | 9 | 2021 | 2585 | 0.380 |
Why?
|
| Endoscopy | 3 | 2020 | 385 | 0.380 |
Why?
|
| Stroke Volume | 5 | 2022 | 464 | 0.380 |
Why?
|
| Cardiac Output | 5 | 2020 | 142 | 0.370 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2013 | 66 | 0.370 |
Why?
|
| Shock, Cardiogenic | 4 | 2017 | 183 | 0.370 |
Why?
|
| Reoperation | 7 | 2020 | 727 | 0.350 |
Why?
|
| Heart Injuries | 1 | 2011 | 23 | 0.340 |
Why?
|
| Atrial Fibrillation | 4 | 2018 | 461 | 0.340 |
Why?
|
| Chordae Tendineae | 3 | 2015 | 20 | 0.340 |
Why?
|
| Aortic Aneurysm | 2 | 2025 | 72 | 0.330 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 108 | 0.320 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2011 | 119 | 0.310 |
Why?
|
| Proportional Hazards Models | 6 | 2020 | 922 | 0.310 |
Why?
|
| Mathematical Concepts | 2 | 2020 | 18 | 0.300 |
Why?
|
| Endovascular Procedures | 3 | 2025 | 399 | 0.300 |
Why?
|
| Bioprosthesis | 3 | 2017 | 42 | 0.300 |
Why?
|
| Thoracotomy | 3 | 2021 | 71 | 0.300 |
Why?
|
| Postoperative Hemorrhage | 1 | 2010 | 55 | 0.300 |
Why?
|
| Risk Factors | 15 | 2022 | 6233 | 0.290 |
Why?
|
| Hematoma | 1 | 2010 | 106 | 0.290 |
Why?
|
| Anticoagulants | 5 | 2019 | 486 | 0.290 |
Why?
|
| Aorta | 5 | 2022 | 275 | 0.290 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2019 | 57 | 0.280 |
Why?
|
| Injections | 1 | 2008 | 131 | 0.280 |
Why?
|
| Incidence | 7 | 2021 | 1779 | 0.270 |
Why?
|
| Reproducibility of Results | 10 | 2018 | 2784 | 0.270 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2008 | 15 | 0.270 |
Why?
|
| Body Surface Potential Mapping | 1 | 2007 | 34 | 0.260 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2014 | 161 | 0.260 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2015 | 266 | 0.260 |
Why?
|
| Atrial Function, Left | 1 | 2007 | 37 | 0.260 |
Why?
|
| Equipment Design | 5 | 2016 | 425 | 0.260 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2018 | 151 | 0.260 |
Why?
|
| Heart Valve Prosthesis | 3 | 2021 | 97 | 0.250 |
Why?
|
| Gamma Rays | 1 | 2007 | 72 | 0.250 |
Why?
|
| Guanidines | 1 | 2007 | 34 | 0.250 |
Why?
|
| Assisted Circulation | 2 | 2018 | 16 | 0.250 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 71 | 0.250 |
Why?
|
| Hemorrhage | 2 | 2018 | 299 | 0.240 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2008 | 121 | 0.240 |
Why?
|
| Recurrence | 5 | 2018 | 1254 | 0.240 |
Why?
|
| Tachycardia, Ventricular | 1 | 2007 | 180 | 0.230 |
Why?
|
| Intracranial Hemorrhages | 1 | 2007 | 138 | 0.230 |
Why?
|
| Animals | 17 | 2017 | 28904 | 0.230 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 2 | 2020 | 42 | 0.220 |
Why?
|
| Liver Transplantation | 1 | 2012 | 1235 | 0.220 |
Why?
|
| Fibronectins | 1 | 2005 | 104 | 0.220 |
Why?
|
| Bloodless Medical and Surgical Procedures | 1 | 2025 | 7 | 0.220 |
Why?
|
| Xiphoid Bone | 3 | 2009 | 3 | 0.220 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 382 | 0.220 |
Why?
|
| Models, Animal | 2 | 2016 | 279 | 0.210 |
Why?
|
| Treatment Refusal | 1 | 2025 | 69 | 0.210 |
Why?
|
| Heart Defects, Congenital | 1 | 2007 | 368 | 0.210 |
Why?
|
| Stroke | 4 | 2022 | 1154 | 0.200 |
Why?
|
| Sensitivity and Specificity | 7 | 2017 | 1945 | 0.200 |
Why?
|
| Chicago | 2 | 2019 | 1513 | 0.200 |
Why?
|
| Blood Loss, Surgical | 1 | 2025 | 140 | 0.200 |
Why?
|
| Atrial Appendage | 2 | 2018 | 45 | 0.200 |
Why?
|
| Blood Transfusion | 1 | 2025 | 180 | 0.200 |
Why?
|
| Pulmonary Artery | 2 | 2020 | 342 | 0.200 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 440 | 0.200 |
Why?
|
| Endocarditis | 2 | 2021 | 26 | 0.190 |
Why?
|
| Registries | 4 | 2022 | 1122 | 0.190 |
Why?
|
| Equipment Failure | 4 | 2018 | 119 | 0.190 |
Why?
|
| Central Venous Pressure | 2 | 2020 | 28 | 0.190 |
Why?
|
| Hypothermia | 1 | 2022 | 27 | 0.190 |
Why?
|
| Myocardial Contraction | 3 | 2015 | 193 | 0.190 |
Why?
|
| Arterial Pressure | 2 | 2020 | 44 | 0.190 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 630 | 0.180 |
Why?
|
| Exercise Tolerance | 2 | 2020 | 67 | 0.180 |
Why?
|
| Prostheses and Implants | 2 | 2016 | 127 | 0.180 |
Why?
|
| Hypothermia, Induced | 1 | 2022 | 95 | 0.180 |
Why?
|
| Proof of Concept Study | 1 | 2022 | 63 | 0.170 |
Why?
|
| Blood Flow Velocity | 2 | 2019 | 179 | 0.170 |
Why?
|
| Aortic Diseases | 1 | 2022 | 88 | 0.170 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2015 | 85 | 0.170 |
Why?
|
| Feasibility Studies | 6 | 2020 | 801 | 0.170 |
Why?
|
| Propensity Score | 1 | 2022 | 213 | 0.170 |
Why?
|
| Perfusion | 2 | 2022 | 271 | 0.170 |
Why?
|
| Aortic Valve Stenosis | 2 | 2017 | 156 | 0.170 |
Why?
|
| Image Enhancement | 4 | 2017 | 503 | 0.170 |
Why?
|
| Cerebrovascular Circulation | 2 | 2022 | 239 | 0.170 |
Why?
|
| Ischemic Attack, Transient | 1 | 2022 | 195 | 0.170 |
Why?
|
| Patient Readmission | 3 | 2020 | 425 | 0.170 |
Why?
|
| Coronary Artery Disease | 2 | 2020 | 387 | 0.170 |
Why?
|
| Dogs | 5 | 2010 | 639 | 0.160 |
Why?
|
| Axillary Artery | 1 | 2020 | 12 | 0.160 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 41 | 0.160 |
Why?
|
| Cause of Death | 2 | 2018 | 278 | 0.160 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 47 | 0.160 |
Why?
|
| Ambulatory Care | 2 | 2018 | 201 | 0.160 |
Why?
|
| Foreign Bodies | 1 | 2020 | 61 | 0.160 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 2013 | 0.160 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 98 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 3606 | 0.150 |
Why?
|
| Hemoglobins | 2 | 2018 | 198 | 0.150 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 111 | 0.150 |
Why?
|
| Breath Holding | 2 | 2017 | 26 | 0.150 |
Why?
|
| Tissue Donors | 1 | 2023 | 581 | 0.150 |
Why?
|
| Vena Cava, Inferior | 1 | 2020 | 140 | 0.150 |
Why?
|
| Drainage | 1 | 2020 | 176 | 0.150 |
Why?
|
| Postoperative Period | 1 | 2020 | 321 | 0.150 |
Why?
|
| Electric Impedance | 1 | 2020 | 118 | 0.150 |
Why?
|
| Chi-Square Distribution | 2 | 2018 | 360 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 903 | 0.150 |
Why?
|
| Delayed-Action Preparations | 2 | 2018 | 126 | 0.140 |
Why?
|
| Heparin | 1 | 2019 | 182 | 0.140 |
Why?
|
| Pneumonia, Aspiration | 1 | 2018 | 20 | 0.140 |
Why?
|
| Heart Function Tests | 1 | 2018 | 29 | 0.140 |
Why?
|
| Electromagnetic Phenomena | 2 | 2008 | 17 | 0.140 |
Why?
|
| Donor Selection | 1 | 2019 | 86 | 0.140 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2018 | 28 | 0.140 |
Why?
|
| Predictive Value of Tests | 6 | 2021 | 1782 | 0.140 |
Why?
|
| Neuromuscular Blockade | 1 | 2018 | 29 | 0.140 |
Why?
|
| Acute Disease | 4 | 2025 | 860 | 0.140 |
Why?
|
| Academic Medical Centers | 2 | 2018 | 413 | 0.140 |
Why?
|
| Operative Time | 1 | 2019 | 175 | 0.140 |
Why?
|
| Prosthesis Failure | 3 | 2016 | 117 | 0.140 |
Why?
|
| Cicatrix | 1 | 2018 | 78 | 0.140 |
Why?
|
| Intraoperative Care | 1 | 2018 | 90 | 0.140 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 372 | 0.140 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 153 | 0.140 |
Why?
|
| Enoxaparin | 1 | 2018 | 27 | 0.140 |
Why?
|
| Octreotide | 1 | 2018 | 32 | 0.130 |
Why?
|
| Secondary Prevention | 1 | 2018 | 186 | 0.130 |
Why?
|
| Algorithms | 5 | 2017 | 2002 | 0.120 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 237 | 0.120 |
Why?
|
| Patient Selection | 1 | 2020 | 726 | 0.120 |
Why?
|
| Prognosis | 5 | 2018 | 4116 | 0.120 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 80 | 0.120 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 2573 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 382 | 0.120 |
Why?
|
| Subtraction Technique | 1 | 2016 | 126 | 0.120 |
Why?
|
| Hospitalization | 1 | 2022 | 991 | 0.110 |
Why?
|
| Action Potentials | 2 | 2018 | 611 | 0.110 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 30 | 0.110 |
Why?
|
| Sus scrofa | 1 | 2015 | 49 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 1009 | 0.110 |
Why?
|
| Jehovah's Witnesses | 1 | 2015 | 21 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 2666 | 0.110 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2016 | 81 | 0.110 |
Why?
|
| Ultrasonography | 2 | 2015 | 720 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1284 | 0.110 |
Why?
|
| Myocardial Infarction | 2 | 2017 | 396 | 0.110 |
Why?
|
| Coronary Vessels | 1 | 2016 | 178 | 0.110 |
Why?
|
| Tissue and Organ Procurement | 1 | 2019 | 423 | 0.100 |
Why?
|
| Heart Septum | 1 | 2014 | 45 | 0.100 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 289 | 0.100 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 166 | 0.100 |
Why?
|
| Hemolysis | 1 | 2013 | 66 | 0.100 |
Why?
|
| Illinois | 3 | 2019 | 522 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2018 | 1527 | 0.090 |
Why?
|
| Ribs | 1 | 2012 | 48 | 0.090 |
Why?
|
| Software | 1 | 2017 | 693 | 0.090 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2017 | 255 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 283 | 0.090 |
Why?
|
| Therapeutics | 1 | 2011 | 13 | 0.090 |
Why?
|
| Quality of Life | 1 | 2020 | 1895 | 0.080 |
Why?
|
| Biomarkers | 1 | 2018 | 2020 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2011 | 221 | 0.080 |
Why?
|
| Cerebrovascular Disorders | 1 | 2011 | 139 | 0.080 |
Why?
|
| Saphenous Vein | 1 | 2010 | 61 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 302 | 0.080 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2010 | 86 | 0.080 |
Why?
|
| United States | 6 | 2020 | 8197 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2010 | 889 | 0.070 |
Why?
|
| Absorbable Implants | 1 | 2009 | 38 | 0.070 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2010 | 116 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2011 | 726 | 0.070 |
Why?
|
| Vacuum | 1 | 2008 | 10 | 0.070 |
Why?
|
| Mitral Valve Prolapse | 1 | 2008 | 18 | 0.070 |
Why?
|
| Polyethylene Terephthalates | 1 | 2008 | 19 | 0.070 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2008 | 21 | 0.070 |
Why?
|
| Coloring Agents | 1 | 2008 | 70 | 0.070 |
Why?
|
| Heart Septal Defects | 1 | 2008 | 28 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2009 | 234 | 0.070 |
Why?
|
| Capillaries | 1 | 2008 | 86 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 802 | 0.070 |
Why?
|
| Pressure | 1 | 2008 | 173 | 0.070 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 88 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 1815 | 0.070 |
Why?
|
| Benzamidines | 1 | 2007 | 3 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 7389 | 0.060 |
Why?
|
| Exercise Test | 2 | 2019 | 158 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 137 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2023 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 557 | 0.060 |
Why?
|
| Collagen | 1 | 2008 | 313 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2008 | 194 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 889 | 0.060 |
Why?
|
| Sex Factors | 2 | 2021 | 1138 | 0.060 |
Why?
|
| Urinary Bladder | 1 | 2008 | 261 | 0.060 |
Why?
|
| Reference Values | 2 | 2018 | 608 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 945 | 0.060 |
Why?
|
| Age Factors | 2 | 2022 | 1962 | 0.060 |
Why?
|
| Actins | 1 | 2008 | 480 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 895 | 0.050 |
Why?
|
| Aortography | 1 | 2025 | 60 | 0.050 |
Why?
|
| Disease Progression | 2 | 2020 | 1610 | 0.050 |
Why?
|
| Observer Variation | 2 | 2016 | 579 | 0.050 |
Why?
|
| Cell Movement | 1 | 2007 | 815 | 0.050 |
Why?
|
| Child | 1 | 2015 | 7681 | 0.050 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 6 | 0.050 |
Why?
|
| Respiration | 2 | 2017 | 274 | 0.050 |
Why?
|
| Coronary Angiography | 2 | 2016 | 237 | 0.050 |
Why?
|
| Temperature | 1 | 2022 | 442 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2021 | 176 | 0.040 |
Why?
|
| Abscess | 1 | 2021 | 94 | 0.040 |
Why?
|
| Rats | 1 | 2007 | 4071 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2020 | 46 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2020 | 102 | 0.040 |
Why?
|
| Hemodynamic Monitoring | 1 | 2019 | 12 | 0.040 |
Why?
|
| Mammary Arteries | 1 | 2020 | 33 | 0.040 |
Why?
|
| Global Health | 1 | 2021 | 215 | 0.040 |
Why?
|
| Materials Testing | 1 | 2019 | 96 | 0.040 |
Why?
|
| Atracurium | 1 | 2018 | 5 | 0.040 |
Why?
|
| Epicardial Mapping | 1 | 2018 | 12 | 0.040 |
Why?
|
| Succinylcholine | 1 | 2018 | 14 | 0.040 |
Why?
|
| Systole | 1 | 2019 | 81 | 0.040 |
Why?
|
| Stents | 1 | 2022 | 433 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 370 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2018 | 63 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 38 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2019 | 269 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2017 | 17 | 0.030 |
Why?
|
| Pneumonia | 1 | 2018 | 195 | 0.030 |
Why?
|
| Gadolinium | 1 | 2017 | 95 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 10080 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2016 | 29 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 126 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 194 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 7507 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 197 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 296 | 0.030 |
Why?
|
| Artifacts | 1 | 2017 | 248 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 878 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2015 | 162 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 92 | 0.030 |
Why?
|
| New York | 1 | 2014 | 80 | 0.030 |
Why?
|
| Stomach | 1 | 2015 | 110 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1950 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2016 | 492 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2015 | 418 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2013 | 63 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2020 | 4001 | 0.020 |
Why?
|
| Basilar Artery | 1 | 2011 | 42 | 0.020 |
Why?
|
| Contrast Media | 1 | 2017 | 1011 | 0.020 |
Why?
|
| Acceleration | 1 | 2011 | 20 | 0.020 |
Why?
|
| Intracranial Thrombosis | 1 | 2011 | 31 | 0.020 |
Why?
|
| Vertebral Artery | 1 | 2011 | 33 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2011 | 199 | 0.020 |
Why?
|
| Vascular Patency | 1 | 2010 | 123 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 162 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2010 | 92 | 0.020 |
Why?
|
| Locomotion | 1 | 2011 | 150 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 128 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2009 | 88 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 230 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2008 | 108 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 1384 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 397 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1275 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 1751 | 0.010 |
Why?
|